Document is current
Any future updates will be listed below
-
Authors
Kim, Woori
Cho, Michael H.
Sakornsakolpat, Phuwanat
Lynch, David A.
Coxson, Harvey O.
Tal-Singer, Ruth
Silverman, Edwin K.
Beaty, Terri H. http://orcid.org/0000-0002-7644-1705
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01 HL089897)
National Heart, Lung, and Blood Institute (U01 HL089856)
COPD Foundation
GlaxoSmithKline (NCT00292552)
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 12 June 2019
First Online: 19 July 2019
Ethics approval and consent to participate
: COPDGene and ECLIPSE has been approved by the Institutional Review Board at each of clinical sites. All participants provided written informed consent for their medical data to be used prior to taking part in the study.
: Not applicable.
: MHC has received grant funding from GSK and consulting fees from Genentech. RTS are employees and shareholders of GSK. EKS: In the past three years, EKS received grant and travel support from GlaxoSmithKline. WK, PS, DAL, HOC and THB declare that they have no competing interests.
